Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018140510) COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE AND OTHER CNS DISORDERS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/140510 International Application No.: PCT/US2018/015068
Publication Date: 02.08.2018 International Filing Date: 24.01.2018
IPC:
A61K 39/395 (2006.01) ,A61P 9/10 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
10
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applicants:
BIOGEN MA INC. [US/US]; 225 Binney Street Cambridge, MA 02142, US
Inventors:
MEHTA, Lahar, R.; US
KANDADI MURALIDHARAN, Bharath, Kumar; US
ELKINS, Jacob; US
NESTOROV, Ivan; US
Agent:
COLLAZO, Diana, M.; US
SCHAFHEIMER, Steven, Nathaniel; US
YANG, Peter; US
Priority Data:
62/450,44525.01.2017US
62/587,26116.11.2017US
Title (EN) COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE AND OTHER CNS DISORDERS
(FR) COMPOSITION ET MÉTHODES DE TRAITEMENT D'UN ACCIDENT VASCULAIRE CÉRÉBRAL ET D'AUTRES TROUBLES DU SNC
Abstract:
(EN) The invention relates to methods of treating stroke comprising administration of a VLA-4 antagonist to a subject after the onset of the stroke, e.g., ischemic stroke (e.g., acute ischemic stroke) or hemorrhagic stroke (e.g., intracerebral hemorrhage or subarachnoid hemorrhage), or traumatic brain injury. Kits and articles of manufacture are also described herein.
(FR) L'invention concerne des méthodes de traitement d'un accident vasculaire cérébral qui consistent à administrer un antagoniste de VLA-4 à un sujet après l’apparition de l'accident vasculaire cérébral, par exemple, un AVC ischémique (par exemple, un AVC ischémique aigu) ou un accident vasculaire cérébral hémorragique (par exemple, une hémorragie intracérébrale ou une hémorragie sous-arachnoïdienne), ou une lésion cérébrale traumatique. L'invention concerne également des kits et des articles manufacturés associés.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)